One study suggests that higher levels of erythrocyte protoporphyrin are a major determinant of disease severity and risk of liver dysfunction in patients with EPP or XLPP (1).
One study suggests that higher levels of erythrocyte protoporphyrin are a major determinant of disease severity and risk of liver dysfunction in patients with EPP or XLPP (1).